Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › About Us › Our Staff › staff reporter

staff reporter

Email
[email protected]

Articles Authored by staff reporter

Nov 25, 2020

Somalogic Closes $121M Series A Funding

The company said it will use proceeds from the round, which was led by Casdin Capital, to expand and commercialize its SomaScan platform and SomaSignal tests.

Nov 25, 2020

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

The FDA also reissued Emergency Use Authorizations for SARS-CoV-2 tests from Roche and Express Gene to reflect their permitted use with additional sample types.

Nov 25, 2020

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

The ELISA-based test has shown 98.8 percent sensitivity and 99.6 percent specificity for detecting SARS-CoV-2 specific IgG against two virus antigens.

Nov 24, 2020

In Brief This Week: Quest Diagnostics, Fluidigm, BD, and More

News items for the in vitro diagnostics industry for the week of Nov. 23, 2020.

Nov 24, 2020

Tempus Gets CE Mark for xT Tumor Sequencing Assay

The xT platform integrates structured clinical patient data with results from a 648-gene DNA panel and whole-transcriptome RNA sequencing.

Nov 24, 2020

BTIG Downgrades Fulgent Genetics from Buy to Neutral

The investment bank said it expects demand for Fulgent's COVID-19 testing to decline over the next two years.

Nov 24, 2020

Cepheid Receives CE Mark for SARS-CoV-2, Flu A/B, RSV Combination Test

Cepheid said that the 4-in-1 test runs on any of almost 30,000 GeneXpert Systems, which provide results in approximately 36 minutes.

Nov 24, 2020

OpGen Inks $10M Private Placement Agreement

Under the terms of the agreement, OpGen would sell $10 million in stock and warrants to a US-based healthcare-focused institutional investor.

Nov 23, 2020

Agilent Q4 Revenues Rise 8 Percent

For the three months ended Oct. 31, revenues rose to $1.48 billion from $1.37 billion in Q4 2019, beating the average Wall Street estimate of $1.4 billion.

Nov 23, 2020

Scope Fluidics Secures €6.2M Supporting Rapid MDx

The Warsaw, Poland-based firm has secured nearly €20 million ($23.7 million) this year to advance its PCR One point-of-care molecular diagnostic system.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.